Detalhe da pesquisa
1.
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial.
J Infect Dis
; 225(11): 1923-1932, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35079784
2.
Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
mBio
; 14(1): e0339322, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36728420
3.
Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers.
Sci Adv
; 9(44): eadh4379, 2023 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37910620
4.
A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy.
JCI Insight
; 7(22)2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509287
5.
Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity.
Front Oncol
; 11: 778989, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34869028
6.
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
mBio
; 12(2)2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33879594
7.
Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein.
ACS Pharmacol Transl Sci
; 4(4): 1349-1361, 2021 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34396059
8.
Erratum for Adeniji et al., "COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions".
mBio
; 12(3): e0124421, 2021 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34098736